A Retrospective Review of Drug Challenges over 5 Years in a Pediatric Population

2010 ◽  
Vol 125 (2) ◽  
pp. AB153
Author(s):  
S. Kamboj ◽  
S.J. McGeady ◽  
E. Yousef ◽  
J. Hossain
2014 ◽  
Vol 34 (4) ◽  
pp. 459-461 ◽  
Author(s):  
Brian Schloss ◽  
Tarun Bhalla ◽  
Kevin Klingele ◽  
Daniel Phillips ◽  
Bradley Prestwich ◽  
...  

2020 ◽  
Vol 8 (1) ◽  
pp. 407-408 ◽  
Author(s):  
David Lutz ◽  
Allison Ramsey ◽  
Kelly Conn ◽  
S. Shahzad Mustafa

2019 ◽  
Vol 60 (1) ◽  
pp. 7-15 ◽  
Author(s):  
Wan Xuan Selina Lim ◽  
Wen Bing Brandon Chua ◽  
Jie Min Chua ◽  
Qianyu Lee ◽  
Jer Wei Chan ◽  
...  

2019 ◽  
Vol 16 (3) ◽  
pp. 40-42
Author(s):  
Subash Lohani ◽  
Aashish Baniya

Ventriculo-Peritoneal shunt is significantly associated with complications like malfunction and infection. In this study, we aim to review our infection and malfunction rate. This is a retrospective review of charts of patients who underwent ventriculo-peritonealshunt at Upendra Devkota Memorial National Institute of Neurological and Allied Sciences, Bansbari, Nepal between 2008 and 2018. Patients were interviewed via telephone for information regarding shunt complications in the form of malfunction, infection, and the need for revision. A total of 357 patients underwent ventriculoperitonealshunt over a period of 10 years.   of patients was 37.08 years. There were224 males and133 females with M:F::1.7:1.265 patients were available over telephone for interview. 54 of 265 (20.37%) patients needed shunt revision. 32 (12.07%) of them had shunt malfunction. 21 (7.92%) of them had shunt infection. One (0.37%) patient had problems with over drainage. Shunt complications were proportionate in pediatric population as well. Shunt complication at Upendra Devkota Memorial National Institute of Neurological and Allied Sciences is comparable to international data.


2015 ◽  
Vol 101 (1) ◽  
pp. e1.4-e1
Author(s):  
Victoria C. Ziesenitz ◽  
Johannes N. van den Anker ◽  
Maryann Amirshahi

IntroductionUS legislative efforts over the past two decades have attempted to promote therapeutic equity for the pediatric population. The objective of this study was to explore trends in the availability of pediatric formulations for the most commonly prescribed drugs in US pediatric ambulatory care.MethodsA retrospective review of the CDC's National Ambulatory Care Survey (NAMCS) from 2002–10 was performed focusing on visits involving children<6 years. The top 100 medications prescribed for which an oral dosage form was available were identified. The availability of a pediatric specific formulation was determined from FDA labeling data. Trends were compared between 2002 and 2010.ResultsIn total, 94,152,217 prescriptions in 2002 and 2010 were analyzed. The most often prescribed drugs were anti-infectives (52.8 vs. 41.6%), respiratory agents (19.2 vs. 21.7%) and antipyretics/ analgesics (14.6 vs. 21.1%). In 2002, a pediatric formulation was available for 94.4% of prescriptions in comparison 95.5% in 2010 (p<0.05). Pediatric formulations were more commonly available for anti-infectives (95.3 vs. 95.9%), antipyretics/ analgesics (99.8 vs. 99.4%) as well as for respiratory (99.5 vs. 98.7%), endocrinologic (80.2 vs. 95.7%), and gastrointestinal (92.6 vs. 97.9%) agents, whereas pediatric formulations were lacking for cardiovascular (68.0 vs. 52.1%), neurologic (46.6 vs. 55.2%) and psychotherapeutic drugs (76.3 vs. 66.1%, all p<0.05).ConclusionSince the US Best Pharmaceuticals for Children Act 2002, more pediatric specific formulations have become available. Anti-infective agents, respiratory agents and antipyretics/analgesics have been the most commonly prescribed drugs in children <6 years.


Sign in / Sign up

Export Citation Format

Share Document